Amedisys, Inc.
(NASDAQ GS: AMED)
Rigrodsky Law, P.A. is investigating Amedisys, Inc. (“Amedisys”) regarding possible breaches of fiduciary duties and other violations of law related to Amedisys’ agreement to be acquired by Optum. Under the terms of the agreement, Amedisys shareholders will receive $101.00 per share in cash.